NPPNY
Price
$6.89
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
NXSCF
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
Ad is loading...

NPPNY vs NXSCF

Header iconNPPNY vs NXSCF Comparison
Open Charts NPPNY vs NXSCFBanner chart's image
Nippon Shinyaku
Price$6.89
Change-$0.00 (-0.00%)
Volume$2.97K
CapitalizationN/A
NEXT SCIENCE
Price$0.10
Change-$0.00 (-0.00%)
Volume$1.8K
CapitalizationN/A
NPPNY vs NXSCF Comparison Chart
Loading...
View a ticker or compare two or three
VS
NPPNY vs. NXSCF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPPNY is a Hold and NXSCF is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (NPPNY: $6.89 vs. NXSCF: $0.10)
Brand notoriety: NPPNY and NXSCF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NPPNY: 319% vs. NXSCF: 12%
Market capitalization -- NPPNY: $2.75B vs. NXSCF: $82.26M
NPPNY [@Pharmaceuticals: Other] is valued at $2.75B. NXSCF’s [@Pharmaceuticals: Other] market capitalization is $82.26M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NPPNY’s FA Score shows that 1 FA rating(s) are green whileNXSCF’s FA Score has 0 green FA rating(s).

  • NPPNY’s FA Score: 1 green, 4 red.
  • NXSCF’s FA Score: 0 green, 5 red.
According to our system of comparison, NPPNY is a better buy in the long-term than NXSCF.

Price Growth

NPPNY (@Pharmaceuticals: Other) experienced а +2.30% price change this week, while NXSCF (@Pharmaceuticals: Other) price change was -2.40% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +56.20%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -6.95%.

Industries' Descriptions

@Pharmaceuticals: Other (+56.20% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
NPPNY($2.75B) has a higher market cap than NXSCF($82.3M). NPPNY YTD gains are higher at: -17.965 vs. NXSCF (-53.524). NPPNY has higher annual earnings (EBITDA): 36B vs. NXSCF (-11.94M). NPPNY has more cash in the bank: 64.4B vs. NXSCF (7.37M). NXSCF has less debt than NPPNY: NXSCF (276K) vs NPPNY (2.11B). NPPNY has higher revenues than NXSCF: NPPNY (141B) vs NXSCF (10.4M).
NPPNYNXSCFNPPNY / NXSCF
Capitalization2.75B82.3M3,337%
EBITDA36B-11.94M-301,560%
Gain YTD-17.965-53.52434%
P/E Ratio16.53N/A-
Revenue141B10.4M1,355,769%
Total Cash64.4B7.37M874,050%
Total Debt2.11B276K764,493%
FUNDAMENTALS RATINGS
NPPNY: Fundamental Ratings
NPPNY
OUTLOOK RATING
1..100
47
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
61
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

NPPNY and

Correlation & Price change

A.I.dvisor tells us that NPPNY and MKKGY have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NPPNY and MKKGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPPNY
1D Price
Change %
NPPNY100%
N/A
MKKGY - NPPNY
11%
Poorly correlated
-3.99%
MEDIF - NPPNY
11%
Poorly correlated
-1.70%
OVATF - NPPNY
9%
Poorly correlated
N/A
NXSCF - NPPNY
5%
Poorly correlated
-1.71%
OMID - NPPNY
1%
Poorly correlated
-19.30%
More

NXSCF and

Correlation & Price change

A.I.dvisor tells us that NXSCF and MVMDF have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NXSCF and MVMDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXSCF
1D Price
Change %
NXSCF100%
-1.71%
MVMDF - NXSCF
13%
Poorly correlated
-3.75%
PCYN - NXSCF
8%
Poorly correlated
N/A
OMID - NXSCF
7%
Poorly correlated
-19.30%
NPPNY - NXSCF
5%
Poorly correlated
N/A
PCLOF - NXSCF
5%
Poorly correlated
-6.93%
More